We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Angion Biomedica Signs Licensing Option with Memorial Sloan Kettering Cancer Center

News   Jan 09, 2009

 
Angion Biomedica Signs Licensing Option with Memorial Sloan Kettering Cancer Center
 
 
 

RELATED ARTICLES

Even Short-term Vaping Causes Inflammation in Non-smokers, Says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

Revival of 50,000-Year-Old Gene Reveals How Deadliest Malaria Parasite Jumped From Gorillas to Humans

News

In a study published today in PLOS Biology, researchers from the Wellcome Sanger Institute and the University of Montpellier have reconstructed a ~50,000-year-old gene sequence acquired by the ancestor of Plasmodium falciparum. The acquisition of the gene sequence enabled the parasite to infect human red blood cells.

READ MORE

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE